Bill Cassidy says new FDA chief lacks needed drug and medical device experience

EXCLUSIVE — Senate Health, Education, Labor, and Pensions Committee Chairman Bill Cassidy (R-LA) said the new acting Food and Drug Administration commissioner, Kyle Diamantas, does not have the prerequisite expertise to oversee the agency’s complex medical device and pharmaceutical oversight. President Donald Trump’s first commissioner, Dr. Marty Makary, abruptly resigned from office on Tuesday a
Source
Washington Examiner
Opens original article in a new tab



